Commercialization Phase Brings New Challenges To Nanotech Industry
This article was originally published in The Tan Sheet
Executive Summary
Increased industry/government collaboration is needed in the field of nanotechnology to move out of the research and development phase and into the commercialization phase, speakers told the President's Council of Advisors on Science and Technology during a June 25 meeting
You may also be interested in...
EPA Would Regulate Nano Materials Under Research Project’s Proposal
A report commissioned by the Project on Emerging Nanotechnologies proposes a five-year strategy lawmakers and the Environmental Protection Agency, among others, can follow to create an "intelligent" approach to nanotechnology oversight
Nanotech Experts Question Whether Regulatory “Gaps” Affect Consumers
Nanotechnology experts, speaking at a meeting organized for FDA's Internal Nanotechnology Task Force, debated whether gaps in FDA's regulation of the technology actually represent problems for the industry and consumers
Task Force To Develop Approaches To Nanotechnology In Drugs, Foods
FDA's Nanotechnology Task Force will identify policy gaps related to the use of nanotechnology particles to evaluate possible adverse health effects from products that contain the materials, the agency said